Spots Global Cancer Trial Database for Tomotherapy for Refractory Brain Metastases
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Tomotherapy for Refractory Brain Metastases
Official Title: Tomotherapy for Refractory Brain Metastases: a Single Arm, Single Center Phase II Trial
Study ID: NCT03027544
Conditions
Interventions
Study Description
Brief Summary: This clinical trial was designed to investigate the efficiency and toxicity of tomotherapy for refractory brain metastases.
Detailed Description: This is a single-arm, single center, phase II trial to investigate the feasibility and toxicity of tomotherapy for refractory brain metastases, which are defined as A: multiple brain metastases(≥3 lesions); B: large brain metastases(with one lesion's volume is no smaller than 6cc or the longest diameter is no shorter than 3cm); C: meningeal metastases.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Chinese Academy of Medical Sciences, Beijing, Beijing, China
Contact Details
Name: Jianping Xiao
Affiliation: Chinese Academy of Medical Sciences
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
